CYTOPENIA AND REPRODUCTIVE OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN ASSESSMENT OF PATIENT ATTITUDES AND FAMILY PLANNING

Introduction. Systemic lupus erythematosus (SLE) is an autoimmune, chronic disease, that can affect multiple organ systems, with a wide range of manifestations, including hematologic involvement. SLE is known to reduce both primary and secondary fertility of women affected by it. In this study, we explore the Influence of cytopenia on reproductive decisions and attitudes in women with SLE in Jordan. Methods. This cross-sectional study, which took place at the rheumatology clinic at a tertiary hospital in Amman, Jordan, enrolled all consecutive SLE patients who presented between the period from September 20233 to March 2024. Data was collected via a structured questionnaire and the review of patients’ charts, and cytopenia was defined by the presence of at least one hematological cell-line cytopenia. Results. We analyzed a total of 64 female patients with SLE, of whom thirty-nine patients (60.9%) had cytopenia, and twenty-five (39.1%) did not. Patients with cytopenia were slightly younger than those without cytopenia (38.23 ± 14.94 vs. 42.64 ± 15.96 years) and had a similar age at SLE diagnosis (27.84 ± 11.55 vs. 29.40 ± 12.97 years). The proportion of patients with a history of infertility did not differ significantly between the two groups (12.8% vs. 12.0%, p = 0.325). Notably, consultation by obstetrics and gynecology was significantly more frequent among patients without cytopenia compared with those with cytopenia (20.0% vs. 2.6%, p = 0.036). Conclusions. The presence of cytopenia did not significantly predict infertility or differences in family planning outcomes in SLE. However, cytopenia was associated with heightened reproductive uncertainty and increased likelihood of citing SLE as a reason for not having children. Downloads

Agmon-Levin N, Mosca M, Petri M, Shoenfeld Y. Systemic lupus erythematosus one disease or many? Autoimmunity Reviews. 2012;11(8):593–5. Gergianaki I, Fanouriakis A, Repa A, Tzanakakis M, Adamichou C, Pompieri A, et al. Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece. Annals of the Rheumatic Diseases. 2017;76(12):1992–2000. Jiménez S, Cervera R, Font J, Ingelmo M. The Epidemiology of Systemic Lupus Erythematosus. CRIAI. 2003;25(1):3–12. Bashal F. Hematological Disorders in Patients with Systemic Lupus Erythematosus. Open Rheumatol J. 2013;7:87–95. Alarcón GS, McGwin G, Uribe A, Friedman AW, Roseman JM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis & Rheumatism. 2004;51(3):465–74. Dao KH, Bermas BL. Systemic Lupus Erythematosus Management in Pregnancy. IJWH. 2022;14:199–211. Palagini L, Mosca M, Tani C, Gemignani A, Mauri M, Bombardieri S. Depression and systemic lupus erythematosus: a systematic review. Lupus. 2013;22(5):409–16. Alnaimat F, Hamdan O, Natsheh T, Hamad RB, Amrieh ZA, Ahmad D, et al. Exploring the influence of social support, disease activity, and fibromyalgia on the emotional well-being of women with systemic lupus erythematosus. BMC Rheumatol. 2025;9(1):26. Alnaimat F, Hamdan O, Othman L, Dabbah T, Marar M, Mohammed R. Patient Perspectives on Reproductive Health in Systemic Lupus Erythematosus: Exploring Disease Manifestations, Quality of Life, and the Role of Social Support. IJWH. 2025; 17:1849–62. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539–49. Zimba O, Gasparyan AY. Designing, Conducting, and Reporting Survey Studies: A Primer for Researchers. J Korean Med Sci. 2023;38(48):e403. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology. 2019;71(9):1400–12. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus. N Engl J Med. 2005;353(24):2550–8. Velo-García A, Castro SG, Isenberg DA. The diagnosis and management of the haematologic manifestations of lupus. Journal of Autoimmunity. 2016;74:139–60. Costa Pires T, Caparrós-Ruiz R, Gaspar P, Isenberg DA. Prevalence and outcome of thrombocytopenia in systemic lupus erythematous: single-centre cohort analysis. Clinical and Experimental Rheumatology. 2021;39(3):601–5. Carli L, Tani C, Vagnani S, Signorini V, Mosca M. Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: Prevalence and clinical impact—A systematic literature review. Seminars in Arthritis and Rheumatism. 2015;45(2):190–4. Teke HÜ, Cansu DÜ, Korkmaz C. Detailed features of hematological involvement and medication-induced cytopenia in systemic lupus erythematosus patients: single center results of 221 patients. Eur J Rheumatol. 2017;4(2):87–92. sle-guideline-summary-2025.pdf [Internet]. [cited 2025 Dec 14]. Available from: https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/bltec93920aad624e33/sle-guideline-summary-2025.pdf Dima A, Caraiola S, Delcea C, Ionescu RA, Jurcut C, Badea C. Self-reported disease severity in women with systemic lupus erythematosus. Rheumatol Int. 2019;39(3):533–9. Bortoluzzi A, Marangoni A, Silvagni E, Rozza D, Bartoloni E, Blagojevic J, et al. Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus. Sci Rep. 2025;15(1):35721. Garg S, Hartel I, Sammaritano LR, Askanase A, Bermas BL, Dall’Era M, et al. A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development. Arthritis Care Res (Hoboken). 2025. Online ahead of print doi: 10.1002/acr.25693. Komatsu H, Yagasaki K, Yamauchi H. Fertility decision-making under certainty and uncertainty in cancer patients. Sexual & Reproductive Healthcare. 2018;15:40–5. van Lunsen RHW. Sex, Fertility, Pregnancy, and Parenthood with a Chronic Disease or Other Health Disturbance. In: Geuens S, Polona Mivšek A, Gianotten WoetL, editors. Midwifery and Sexuality. Cham: Springer International Publishing; 2023 p. 207–16. Balık Z, Bayındır Y, Deniz Batu E. Modeling of immunosenescence with aging in systemic lupus erythematosus. AAEE. 2022 Dec 28;1(2):102–7. Prakashini MV. Inflammation, menopause, and women’s health: a rheumatological perspective. AAEE. 2023 Apr 19;2(1):16–22. Barr SG, Zonana-Nacach A, Magder LS, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis & Rheumatism. 1999;42(12):2682–8.